Clinical features and prediction of long-term survival after surgery for perihilar cholangiocarcinoma.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2024
Historique:
received: 13 03 2024
accepted: 20 05 2024
medline: 1 7 2024
pubmed: 1 7 2024
entrez: 1 7 2024
Statut: epublish

Résumé

The treatment of perihilar Cholangiocarcinoma (pCCA) poses specific challenges not only due to its high perioperative complication rates but also due its dismal long-term prognosis with only a few long-term survivors (LTS) among the patients. Therefore, in this analysis characteristics and predictors of LTS in pCCA patients are investigated. In this single center analysis, patients undergoing curative-intent liver resection for pCCA between 2010 and 2022 were categorized into long-term and short-term survivors (STS) excluding perioperative mortality. Binary logistic regression was used to determine key differences between the groups and to develop a prognostic composite variable. This composite variable was subsequently tested in the whole cohort of surgically treated pCCA patients using Cox Regression analysis for cancer-specific survival (CSS). Within a cohort of 209 individuals, 27 patients were identified as LTS (median CSS = 125 months) and 55 patients as STS (median CSS = 16 months). Multivariable analysis identified preoperative portal vein infiltration (OR = 5.85, p = 0.018) and intraoperative packed red blood cell (PRBC) transfusions (OR = 10.29, p = 0.002) as key differences between the groups. A prognostic composite variable based on these two features was created and transferred into a Cox regression model of the whole cohort. Here, the composite variable (HR = 0.35, p<0.001), lymph node metastases (HR = 2.15, p = 0.001) and postoperative complications (HR = 3.06, p<0.001) were identified as independent predictors of CSS. Long-term survival after surgery for pCCA is possible and is strongly negatively associated with preoperative portal vein infiltration and intraoperative PRBC transfusion. As these variables are part of preoperative staging or can be modulated by intraoperative technique, the proposed prognostic composite variable can easily be transferred into clinical management to predict the oncological outcome of patients undergoing surgery for pCCA.

Identifiants

pubmed: 38950006
doi: 10.1371/journal.pone.0304838
pii: PONE-D-24-08836
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0304838

Informations de copyright

Copyright: © 2024 Mantas et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Auteurs

Anna Mantas (A)

Department of Surgery and Transplantation, University Hospital Essen, Essen, Germany.
Department of Surgery and Transplantation, University Hospital RWTH Aachen, Aachen, Germany.

Carlos Constantin Otto (CC)

Department of Surgery and Transplantation, University Hospital Essen, Essen, Germany.
Department of Surgery and Transplantation, University Hospital RWTH Aachen, Aachen, Germany.

Pim B Olthof (PB)

Department of Surgery, Erasmus Medical Center, Rotterdam, The Netherlands.
Department of Surgery, Amsterdam UMC, Amsterdam, The Netherlands.
Department of Surgery, University Medical Center Groningen, Groningen, The Netherlands.

Daniel Heise (D)

Department of Surgery and Transplantation, University Hospital Essen, Essen, Germany.
Department of Surgery and Transplantation, University Hospital RWTH Aachen, Aachen, Germany.

Dieter Paul Hoyer (DP)

Department of Surgery and Transplantation, University Hospital RWTH Aachen, Aachen, Germany.

Philipp Bruners (P)

Department of Diagnostic and Interventional Radiology, University Hospital RWTH Aachen, Aachen, Germany.

Maxim Dewulf (M)

Department of Surgery, Maastricht University Medical Center (MUMC), Maastricht, The Netherlands.

Sven Arke Lang (SA)

Department of Surgery and Transplantation, University Hospital Essen, Essen, Germany.
Department of Surgery and Transplantation, University Hospital RWTH Aachen, Aachen, Germany.

Tom Florian Ulmer (TF)

Department of Surgery and Transplantation, University Hospital Essen, Essen, Germany.
Department of Surgery and Transplantation, University Hospital RWTH Aachen, Aachen, Germany.

Ulf Peter Neumann (UP)

Department of Surgery and Transplantation, University Hospital Essen, Essen, Germany.
Department of Surgery and Transplantation, University Hospital RWTH Aachen, Aachen, Germany.
Department of Surgery, Maastricht University Medical Center (MUMC), Maastricht, The Netherlands.

Jan Bednarsch (J)

Department of Surgery and Transplantation, University Hospital Essen, Essen, Germany.
Department of Surgery and Transplantation, University Hospital RWTH Aachen, Aachen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH